Conservative activist Laura Loomer targets FDA biologics head Vinay Prasad, calling for his firing and labeling him a| Endpoints News
FDA reverses decision on Sarepta's Duchenne gene therapy, allowing limited patient treatment. R.W. Baird analyst Brian Skorney to discuss implications on Post-Hoc Live.| Endpoints News